Dr. Raphael Charles Bosse, MD

Dr. Bosse practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Bosse's NPI, 1962933325, was assigned on March 27, 2017. Dr. Bosse graduated from University of Florida College of Medicine in 2017. Dr. Bosse holds Florida license ME161862.

Dr. Bosse's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Bosse's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Bosse is also affiliated with NCH Baker Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Bosse to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bosse practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Bosse's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bosse is board certified in hematology by the American Board of Internal Medicine. Dr. Bosse is licensed in Florida.

Dmand AI lists chronic anemia among the conditions Dr. Bosse treats.

CMS data shows 62,702 Medicare services from Dr. Bosse across 43 procedure codes in 2024, for 964 Medicare patients. Medicare paid $378,343 for them.

CMS counts 964 Medicare patients who saw Dr. Bosse in 2024. The largest group is 75 to 84, with 450 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bosse's median patient age at 74, with 53% women.

In 2024, Dr. Bosse wrote 583 Medicare Part D claims for 153 patients. 70% of them were for generic drugs. CMS names the drug for 381 of them, across 17 drugs with 11 or more claims each, at $1,234,953 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

Dr. Bosse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bosse as offering telehealth.

Dmand AI links 7 papers to Dr. Bosse, published from 2014 to 2019. 2019 was the busiest year, with 2. Dr. Bosse's most frequent co-authors are Fares Walid Ayoub, MD, Christopher R. Cogle, MD and Martina Cathryn Murphy, MD.

CMS Open Payments shows 344 general payments to Dr. Bosse from 57 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 98% of the total. Pfizer Inc. paid the most, $832.

Dr. Bosse graduated from University of Florida College of Medicine in 2017.

Dr. Bosse is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.